|
PPIP5K1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.572200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.871400E-01 |
| Normal-vs-Stage2 |
7.252800E-01 |
| Normal-vs-Stage3 |
3.528400E-01 |
| Normal-vs-Stage4 |
2.954600E-01 |
| Stage1-vs-Stage2 |
5.654400E-01 |
| Stage1-vs-Stage3 |
1.554640E-01 |
| Stage1-vs-Stage4 |
3.432600E-01 |
| Stage2-vs-Stage3 |
6.522800E-01 |
| Stage2-vs-Stage4 |
2.243600E-01 |
| Stage3-vs-Stage4 |
5.138200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.609800E-01 |
| Normal-vs-AfricanAmerican |
4.057600E-01 |
| Normal-vs-Asian |
6.561400E-01 |
| Caucasian-vs-AfricanAmerican |
4.457000E-01 |
| Caucasian-vs-Asian |
6.449800E-01 |
| AfricanAmerican-vs-Asian |
7.176400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.448800E-01 |
| Normal-vs-Female |
7.890400E-01 |
| Male-vs-Female |
3.792800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.903200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.897600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.725200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.690300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.737400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.319000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.035200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.700000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.086200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.325610E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.587600E-01 |
| Classical-VS-Follicular |
6.759100E-03 |
| Classical-VS-Other |
3.914600E-01 |
| Classical-VS-Normal |
3.259400E-01 |
| Tall-VS-Follicular |
3.626800E-01 |
| Tall-VS-Other |
5.980200E-01 |
| Tall-VS-Normal |
9.247800E-01 |
| Follicular-VS-Other |
9.467600E-01 |
| Follicular-VS-Normal |
1.785010E-01 |
| Other-VS-Normal |
5.202000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.807800E-01 |
| Normal-vs-N1 |
9.149600E-01 |
| N0-vs-N1 |
5.056200E-01 |
|
|
